Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mirabegron (myrbetriq) (1 trial)
Cognitive Dysfunction (Phase 4)
Parkinson Disease (Phase 4)
Urinary Bladder, Overactive (Phase 4)
Trials (1 total)
Trial APIs (1 total)